Rubicon Healthcare Partners is a growth-oriented investment firm focused on Nordic life science companies supplying products, services, and technologies to the healthcare and biopharmaceutical ...

There is an amended and restated offering document dated October 28, 2025, related to the Offering that can be accessed under ...

Company reports $14.3 million in revenue in Q3’25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license ...

LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced a broad strategic ...

Fitness enthusiasts, athletes, and gym regulars can finally ditch the scoops, powders, shaker bottles, and sticky gummies to get their creatine supplements. Fit Foods Ltd., a leading Canadian-based ...

Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolytic viral therapies, today announced a ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

The bone health supplements market is witnessing steady adoption across pharmaceutical companies, nutraceutical manufacturers, healthcare providers, and ...

The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim report for the period January - September 2025. The full report, which is attached in the press release ...

T cells constantly survey the body for signs of infection or malignancy through the recognition of fragments of antigens (peptides) complexed to molecules of the major histocompatibility complex.

Nitric oxide–mediated production of cyclic guanosine 3′,5′-monophosphate (cGMP) is a crucial signal transduction pathway that controls a wide array of biological functions. A new layer of complexity ...